Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Tax Provisions (2016 - 2019)

IGC Pharma (IGC) has disclosed Tax Provisions for 9 consecutive years, with $2000.0 as the latest value for Q1 2019.

  • On a quarterly basis, Tax Provisions changed N/A to $2000.0 in Q1 2019 year-over-year; TTM through Dec 2019 was $2000.0, a N/A change, with the full-year FY2019 number at $2000.0, changed N/A from a year prior.
  • Tax Provisions was $2000.0 for Q1 2019 at IGC Pharma, up from -$58569.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1.4 million in Q4 2015 to a low of -$1.4 million in Q1 2016.
  • A 4-year average of $10050.5 and a median of $3578.5 in 2015 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: skyrocketed 203.39% in 2015, then plummeted 27253.09% in 2016.
  • IGC Pharma's Tax Provisions stood at $1.4 million in 2015, then plummeted by 94.93% to $73000.0 in 2016, then plummeted by 180.23% to -$58569.0 in 2017, then skyrocketed by 103.41% to $2000.0 in 2019.
  • Per Business Quant, the three most recent readings for IGC's Tax Provisions are $2000.0 (Q1 2019), -$58569.0 (Q1 2017), and $73000.0 (Q4 2016).